19.07.2023 07:00 | TM17 | Directorate Changes | RNS |
18.07.2023 14:15 | TM17 | Director/PDMR Shareholding | RNS |
14.07.2023 07:00 | TM17 | Appointment of Joint Corporate Broker | RNS |
12.07.2023 15:36 | TM17 | Director/PDMR Shareholding | RNS |
22.06.2023 14:01 | TM17 | Result of AGM | RNS |
16.06.2023 16:27 | ABDN, TM17 | Holding(s) in Company | RNS |
15.06.2023 15:51 | WTB, TRLS, TM17 | UK shareholder meetings calendar - next 7 days | Alliance |
14.06.2023 08:55 | TM17 | Director/PDMR Shareholding | RNS |
06.06.2023 09:48 | TM17 | IN BRIEF: Team17 hires marketing agency Iris CEO Steve Bell as new CEO | Alliance |
06.06.2023 07:00 | TM17 | Appointment of Group Chief Executive Officer | RNS |
26.05.2023 07:01 | TM17 | Board Update | RNS |
26.05.2023 07:00 | TM17 | Posting of Annual Report and Notice of AGM | RNS |
25.05.2023 16:42 | TM17 | Holding(s) in Company | RNS |
15.05.2023 12:50 | TM17 | Director/PDMR Shareholding | RNS |
28.04.2023 11:08 | TM17 | IN BRIEF: Team17 subsidiary completes Independent Arts acquisition | Alliance |
28.04.2023 07:00 | TM17 | Team17's astragon Acquires Independent Arts | RNS |
13.04.2023 15:40 | TM17 | Issue of Shares | RNS |
12.04.2023 08:20 | TM17 | Director/PDMR Shareholding | RNS |
31.03.2023 11:15 | TM17 | Director/PDMR Shareholding | RNS |
28.03.2023 10:53 | TM17 | Team17 CEO Bestwick to leave post; yearly profit declines | Alliance |
28.03.2023 10:40 | TM17, SBTX | AIM WINNERS & LOSERS: Unbound soars on potential takeover offer | Alliance |
28.03.2023 07:01 | TM17 | Director Update | RNS |
28.03.2023 07:00 | TM17 | Unaudited Final Results 2022 | RNS |
21.03.2023 15:49 | XAR, GSEO, TM17 | UK earnings, trading statements calendar - next 7 days | Alliance |
13.03.2023 16:49 | TM17 | Director/PDMR Shareholding | RNS |
13.03.2023 12:18 | VRCI, SCLP, ROQ | SUMMARY: London listings with exposure to Silicon Valley Bank | Alliance |
13.03.2023 09:05 | TM17 | No Material Exposure to Silicon Valley Bank | RNS |
02.03.2023 07:00 | TM17 | Notice of Results & Analyst/Investor Presentations | RNS |
13.02.2023 13:41 | TM17 | Director/PDMR Shareholding | RNS |
31.01.2023 14:40 | TM17 | Holdings in Company | RNS |
31.01.2023 09:26 | HOC, ECOR, FEVR | LONDON BROKER RATINGS: Barclays cuts Relx; Jefferies raises Team17 | Alliance |
19.01.2023 17:20 | ABDN, TM17 | Holding(s) in Company | RNS |
18.01.2023 12:16 | TM17 | IN BRIEF: Team17 shares up as annual earnings to be ahead of consensus | Alliance |
18.01.2023 11:09 | TM17, JSE | AIM WINNERS & LOSERS: Team17 to beat expectations; IOG "disappointed" | Alliance |
18.01.2023 07:00 | TM17 | Trading Update | RNS |
12.01.2023 09:04 | TM17 | Director/PDMR Shareholding | RNS |
10.01.2023 18:19 | TM17 | Holding(s) in Company | RNS |
09.01.2023 16:52 | AAZ, KZG, SRES | TRADING UPDATES: Equals buys Roqqett; Aviva reappoints DWF | Alliance |
09.01.2023 14:48 | TM17 | Trading Update | RNS |
13.12.2022 15:51 | TM17 | Director/PDMR Shareholding | RNS |
17.11.2022 08:46 | TM17 | Holding(s) in Company | RNS |
11.11.2022 17:13 | TM17 | Director/PDMR Shareholding | RNS |
20.10.2022 12:11 | TM17 | Holding(s) in Company | RNS |
18.10.2022 13:42 | TM17 | Director/PDMR Shareholding | RNS |
13.09.2022 16:32 | TM17 | Director/PDMR Shareholding | RNS |
13.09.2022 09:39 | TM17 | Team17 interim profit falls as revenue growth offset by surging costs | Alliance |
13.09.2022 07:00 | TM17 | Half Year Results | RNS |
06.09.2022 15:53 | GSEO, TRST, TM17 | UK earnings, trading statements calendar - next 7 days | Alliance |
05.09.2022 07:00 | TM17 | Notice of Results & Analyst/Investor presentations | RNS |
12.08.2022 13:29 | TM17 | Director/PDMR Shareholding | RNS |
19.07.2022 09:50 | GAMA, KWS, TM17 | LONDON BROKER RATINGS: Fevertree chopped; Berenberg likes Deliveroo | Alliance |
18.07.2022 17:08 | TM17 | Holding(s) in Company | RNS |
15.07.2022 15:25 | TM17 | Holding(s) in Company | RNS |
14.07.2022 20:20 | HLCL, IQE, AREC | TRADING UPDATES: Quixant expects revenue rise; Cindrigo widens loss | Alliance |
14.07.2022 07:00 | TM17 | Trading Update | RNS |
12.07.2022 15:56 | TM17 | Director/PDMR Shareholding | RNS |
30.06.2022 15:58 | TM17 | Grant of Options to Directors / PDMRs | RNS |
29.06.2022 16:39 | TM17 | Result of AGM | RNS |
27.06.2022 09:55 | WINE, BIG, TM17 | LONDON BROKER RATINGS: Credit Suisse cuts Ocado; Liberum ups Whitbread | Alliance |
22.06.2022 15:48 | ZAIM, XPF, TRIN | UK shareholder meetings calendar - next 7 days | Alliance |
15.06.2022 07:00 | TM17 | Director/PDMR Shareholding | RNS |
01.06.2022 12:00 | TM17 | Posting of Annual Report and Notice of AGM | RNS |
20.05.2022 13:28 | TM17 | Director/PDMR Shareholding | RNS |
17.05.2022 13:22 | TM17 | Director / PDMR Shareholding & Total Voting Rights | RNS |
11.05.2022 17:36 | TM17 | Director/PDMR Shareholding | RNS |
12.04.2022 17:48 | TM17 | Director/PDMR Shareholding | RNS |
05.04.2022 11:06 | TM17 | Second Price Monitoring Extn | RNS |
05.04.2022 11:00 | TM17 | Price Monitoring Extension | RNS |
01.04.2022 09:41 | KWS, TM17, SUPR | LONDON BROKER RATINGS: Citi upgrades Bridgepoint and Lancashire | Alliance |
30.03.2022 15:27 | BOCH, PSDL, INSE | EARNINGS UPDATES: Ebiquity loss widens, makes deals; Team17 profit up | Alliance |
30.03.2022 11:06 | TM17, EEE, BELL | AIM WINNERS & LOSERS: Belluscura in China pact; Team17 warns on costs | Alliance |
30.03.2022 09:51 | TM17, KETL, CAML | LONDON BROKER RATINGS: BofA lifts Bridgepoint; Citi cuts Experian | Alliance |
30.03.2022 07:00 | TM17 | Unaudited Final Results | RNS |
28.03.2022 16:40 | TM17 | Second Price Monitoring Extn | RNS |
28.03.2022 16:35 | TM17 | Price Monitoring Extension | RNS |